832 related articles for article (PubMed ID: 11967825)
21. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
[TBL] [Abstract][Full Text] [Related]
23. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
[TBL] [Abstract][Full Text] [Related]
24. [The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril].
Jiang M
Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):342-4, 396. PubMed ID: 1668233
[TBL] [Abstract][Full Text] [Related]
25. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
Azizi M; Guyene TT; Chatellier G; Ménard J
J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
[TBL] [Abstract][Full Text] [Related]
26. The effects of angiotensin-II on lipolysis in humans.
Townsend RR
Metabolism; 2001 Apr; 50(4):468-72. PubMed ID: 11288044
[TBL] [Abstract][Full Text] [Related]
27. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
28. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
Jackson B; Cubela R; Johnston CI
J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
[TBL] [Abstract][Full Text] [Related]
29. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
30. Short- and long-term glycaemic control and the state of the renin system in type 1 diabetes mellitus.
Stevanovic RD; Fisher ND; Lansang CM; Freeman KD; Hollenberg NK
J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):85-92. PubMed ID: 17703435
[TBL] [Abstract][Full Text] [Related]
31. The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
Björck S
Scand J Urol Nephrol Suppl; 1990; 126():1-51. PubMed ID: 2194280
[TBL] [Abstract][Full Text] [Related]
32. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
[TBL] [Abstract][Full Text] [Related]
33. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
34. [24-hour blood pressure and renal function in cardiac failure during the titration phase of captopril and enalapril].
Osterziel KJ; Dietz R; Abushi A; Kübler W
Z Kardiol; 1990 Nov; 79(11):742-7. PubMed ID: 2278166
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
36. [Effects of enalapril on plasma Ang II level and the expression of AT1 in blood vessel and kidney of type 2 diabetic rats].
Yang J; Xue C; Hu G
Yao Xue Xue Bao; 2005 Mar; 40(3):208-12. PubMed ID: 15952590
[TBL] [Abstract][Full Text] [Related]
37. Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril.
Karlberg BE; Sjöstrand A; Ohman KP
J Hypertens Suppl; 1986 Dec; 4(5):S432-4. PubMed ID: 3033182
[TBL] [Abstract][Full Text] [Related]
38. Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms.
Rashtchizadeh N; Aghaeishahsavari M; Argani H; Noroozianavval M; Veisi P; Ghorbanihaghjo A
Clin Biochem; 2007 Feb; 40(3-4):194-200. PubMed ID: 17222813
[TBL] [Abstract][Full Text] [Related]
39. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Raasch W; Bartels T; Schwartz C; Häuser W; Rütten H; Dominiak P
J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
[TBL] [Abstract][Full Text] [Related]
40. [Role of prostaglandins in the antihypertensive effect of the converting enzyme inhibitor, enalapril].
Espinoza F; Gallego A; Ruiz A; Pérez-Grovas H; Garza Flores J; Morato T; Herrera-Acosta J
Rev Invest Clin; 1989; 41(4):351-60. PubMed ID: 2561022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
